SHARE | PRINT | EMAIL
It is no longer tenable for either product to remain shielded from full scrutiny. Both nirsevimab (Beyfortus) and clesrovimab warrant a thorough re-evaluation by... Read more.
SHARE | PRINT | EMAIL
The Nobel Prize narrative is not a harmless compliment. It is a calculated effort to sanctify one remaining pillar, while the others collapse beneath the evidence.... Read more.
SHARE | PRINT | EMAIL
A recent critique raises a number of claims regarding my article. This response addresses the substantive points directly, focusing solely on the evidence. When... Read more.
SHARE | PRINT | EMAIL
If an advisory committee rebuilt under promises of independence can be steered by incomplete presentations, the issue goes beyond one antibody. At stake is whether... Read more.
SHARE | PRINT | EMAIL
This article tells the story of one of the most disturbing breaches of scientific ethics we’ve encountered in our academic careers—buried in the peer-review... Read more.
SHARE | PRINT | EMAIL
So if Israel did not in fact have a functioning adverse event monitoring system in place and its data was a fiction, and even if when it did launch a proper monitoring... Read more.






